跳至主要内容
临床试验/CTRI/2024/04/065047
CTRI/2024/04/065047尚未招募不适用

Clinical correlation between breast cancer and prognostic significance of ferritin,vitamin D and vitamin B12.

Akansha Hatewar1 个研究点 分布在 1 个国家目标入组 42 人开始时间: 2024年4月10日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
42
试验地点
1
主要终点
1 To estimate levels of serum vit D, Vit B12, and Ferritin in patients with stages of breast cancer.

研究概览

简要总结

In this study, we aim to conduct a comprehensive analysis by comparing serum expression levels of vitamin B12, vitamin D, and ferritin among three distinct groups: healthy individuals, patients with benign breast conditions, and those diagnosed with breast cancer. Our primary focus is to assess the intricate relationship between vitamin B12, vitamin D, and ferritin levels and the associated risk of breast cancer. By examining these parameters across various health conditions, we intend to gain a deeper understanding of how these vitamins may play a pivotal role in breast cancer risk. This research holds the potential to shed valuable light on the connections between these serum markers and the development of breast cancer, ultimately contributing to our knowledge of this complex disease.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 95.00 Year(s)(—)
性别
Female

入选标准

  • 1 Newly diagnosed case of CA breast and biopsy proven.
  • 2 Women aged above 18 years.

排除标准

  • 1 Malignancies other than breast carcinoma 2 Pregnancy/puerperium 3 Known c/o Tuberculosis, Chronic inflammatory diseases 4 Patients infected with hepatitis B and C virus as well as H.I.V. 5 Renal/Hepatic insufficiency 6 Metabolic bone disorders 7 No history of medications such as iron, levothyroxine and vitamin D/B12 supplements in the past three months.

结局指标

主要结局

1 To estimate levels of serum vit D, Vit B12, and Ferritin in patients with stages of breast cancer.

时间窗: 2 years

2 To analyse a correlation between serum vit D, Vit B12, Ferritin with Tumour grade, histopathological subtype and axillary lymph node status.

时间窗: 2 years

3 To correlate between serum vit D, Vit B12, and Ferritin with molecular pathological parameters.

时间窗: 2 years

次要结局

  • 1. In this study we aim to conduct a comprehensive analysis by comparing serum expression levels of vitamin B12 vitamin D & ferritin among three distinct groups healthy individuals patients with benign breast conditions & those diagnosed with breast cancer.(2. Our primary focus is to assess the intricate relationship between vitamin B12 vitamin D & ferritin levels & the associated risk of breast cancer.)

研究者

发起方
Akansha Hatewar
申办方类型
Other [SELF ]
责任方
Principal Investigator
主要研究者

Dr Akansha Hatewar

Datta Meghe Institute Of Higher Education And Research

研究点 (1)

Loading locations...

相似试验

CLINICAL Correlation Between Breast Cancer And... | 临床试验